Overview
- 47 inspections across 42 sites are on record.
- 100 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-05-29.
At a glance
Inspections
47
Sites
42
Observations
100
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fujian Kerui Pharmaceutical Co., Ltd. | 29 May 2015 | Human Drugs | On file |
| Fujian Kerui Pharmaceutical Co., Ltd. | 29 May 2015 | Human Drugs | On file |
| JIANGSU TIANHE PHARMACEUTICAL CO., LTD. | 22 May 2015 | Human Drugs | On file |
| Jiangxi Guoyao Pharmaceutical, LLC, Co. | 15 May 2015 | Human Drugs | On file |
| Brightgene Pharmaceutical Co., Ltd. | 14 Mar 2013 | Human Drugs | On file |
Sites inspected
Fujian Kerui Pharmaceutical Co., Ltd.Fuqing, China1 insp.
Fujian Kerui Pharmaceutical Co., Ltd.Fuzhou, China1 insp.
JIANGSU TIANHE PHARMACEUTICAL CO., LTD.Yangzhou, China1 insp.
Jiangxi Guoyao Pharmaceutical, LLC, Co.Nanchang, China1 insp.
Brightgene Pharmaceutical Co., Ltd.Suzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Felix Maldonado6 shared
Javier O Vega3 shared
James D Bridges2 shared
Karen L Kosar2 shared
Demitria J Xiradakis2 shared
Jose A Lopez Rubet2 shared
Ginger M Sykes2 shared
Carla A Norris2 shared
Susan M Jackson2 shared
Helen B Ricalde1 shared
Full investigator report
Get the verbatim findings behind Kevin A Gonzalez's 100 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site